Inovio Pharmaceuticals
INO
#9349
Rank
โ‚ฌ94.2 M
Marketcap
1,14ย โ‚ฌ
Share price
8.13%
Change (1 day)
-34.76%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -2,53ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,48ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,40ย โ‚ฌ an increase over its 2023 EPS that were of -5,24ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,53ย โ‚ฌ-25.62%
2024-3,40ย โ‚ฌ-35.14%
2023-5,24ย โ‚ฌ-56.62%
2022-12,09ย โ‚ฌ-19.54%
2021-15,02ย โ‚ฌ35.9%
2020-11,05ย โ‚ฌ-11.57%
2019-12,50ย โ‚ฌ15.24%
2018-10,85ย โ‚ฌ-2.78%
2017-11,16ย โ‚ฌ6.93%
2016-10,43ย โ‚ฌ134.88%
2015-4,44ย โ‚ฌ-29.51%
2014-6,30ย โ‚ฌ-57.34%
2013-14,77ย โ‚ฌ146.55%
2012-5,99ย โ‚ฌ20.83%
2011-4,96ย โ‚ฌ-29.41%
2010-7,02ย โ‚ฌ-48.48%
2009-13,64ย โ‚ฌ10%
2008-12,40ย โ‚ฌ11.11%
2007-11,16ย โ‚ฌ-41.3%
2006-19,01ย โ‚ฌ-66.91%
2005-57,44ย โ‚ฌ110.61%
2004-27,27ย โ‚ฌ-61.63%
2003-71,08ย โ‚ฌ186.67%
2002-24,79ย โ‚ฌ
2001N/A-100%
2000-19,84ย โ‚ฌ-62.85%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,52ย โ‚ฌ-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,04ย โ‚ฌ-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,13ย โ‚ฌ-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,90ย โ‚ฌ-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,06ย โ‚ฌ-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,35ย โ‚ฌ-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
0,30ย โ‚ฌ-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA